BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
2.000
-0.350 (-14.89%)
Feb 5, 2026, 1:30 PM EST - Market open
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $4.73 million as of February 5, 2026. Its market cap has decreased by -28.87% in one year.
Market Cap
4.73M
Enterprise Value
2.30M
1-Year Change
-28.87%
Ranking
Category
Stock Price
$2.00
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $4.73M, a decrease of -88.78%. That is a compound annual growth rate of -33.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 5.56M | -40.51% |
| Dec 31, 2025 | 9.34M | 85.79% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FutureFuel | 148.93M |
| Aemetis | 101.63M |
| Northern Technologies International | 83.53M |
| Flexible Solutions International | 74.63M |
| Loop Industries | 59.94M |
| 5E Advanced Materials | 50.55M |
| Trinseo | 16.20M |
| SenesTech | 10.60M |